Current Status


Current clinical trials are being conducted for Transmyocardial Laser Revascularization alone. In this procedure, coronary bypass is not performed. This is called sole therapy. A special high power laser is used to make the channels. The procedure is performed through a limited incision usually made in the side of the chest. This procedure is not as extensive as open heart surgery. It is expected that hospitalization will be less than that required for conventional open heart surgery. St. Luke's Medical Center, Milwaukee, Wisconsin is an approved site for conducting these clinical trials. The aim of the Transmyocardial Laser Revascularization study is to evaluate the effectiveness of laser channels as sole therapy. If effective, this would offer an alternative form of treatment to those suffering from coronary artery disease, particularly those who otherwise would have no other options. Data from all those performing the procedure will be collected, analyzed and reported. Approval from the Food and Drug Administration will be sought if warranted by the results of these studies.
Prevention of angina and protection of the myocardium from infraction.
Channels created by the laser allow blood to flow from the
ventrical and provide nourishment to the heart muscle.
The flow is sufficient to prevent angina and protect the
myocardium from infraction.


Heart and Lung Institute N124 W16862 Lovers Lane Germantown, WI 53022

heartlung@globaldialog.com

    Return to TMLR Info Site